Entera Bio Ltd. announced on November 30, 2020, that its Board of Directors has appointed Spiros Jamas, Sc.D. as CEO and member of the Board of Directors effective January 4, 2021. Dr. Jamas will succeed Dr. Roger Garceau, who has been serving as interim CEO since August 2020. Dr. Garceau will continue to serve as a Director of Entera Bio. Spiros Jamas is a biotech entrepreneur with over 30 years of senior management experience in the biopharmaceutical industry. He has served as CEO and/or founder of multiple high growth, innovation-driven companies including: AOBiome Therapeutics Inc., Tempero Pharmaceuticals Inc., Enanta Pharmaceuticals Inc. and Alpha-Beta Technology Inc.